Page last updated: 2024-11-04

terfenadine and Asialia

terfenadine has been researched along with Asialia in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria."9.09Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000)
"This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria."5.09Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000)
"Allergic rhinitis is manifested by watery discharge; however its clinical effect on the watery volume in the oral cavity is unknown."1.33Saliva secretion in patients with allergic rhinitis. ( Elad, S; Heisler, S; Shalit, M, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elad, S1
Heisler, S1
Shalit, M1
Nelson, HS1
Reynolds, R1
Mason, J1

Trials

1 trial available for terfenadine and Asialia

ArticleYear
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chronic Disease; Disorders of Excessive Somnol

2000

Other Studies

1 other study available for terfenadine and Asialia

ArticleYear
Saliva secretion in patients with allergic rhinitis.
    International archives of allergy and immunology, 2006, Volume: 141, Issue:3

    Topics: Adolescent; Adult; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Patient

2006